Peptide vaccination in the presence of adjuvants in patients after hematopoietic stem cell transplantation with CD4+ T cell reconstitution elicits consistent CD8+ T cell responses
Michael Schmitt(German Cancer Research Center), Jochen Greiner(Universität Ulm), Birgit Maccari(Universität Ulm), Angela Hückelhoven(Heidelberg University), Markus Wiesneth(Universität Ulm), Patrick Wuchter(Heidelberg University), Birgit Michels(University Hospital Heidelberg), Jürgen Kuball(Utrecht University), Anthony D. Ho(Heidelberg University), Hubert Schrezenmeier(German Red Cross), Marlies Götz(Universität Ulm), Volker Eckstein(Heidelberg University), Peter Dreger(Heidelberg University), Hartmut Döhner(University Hospital Ulm), Peter Schauwecker(Universität Ulm), Lei Wang(Xihua University), Susanne Hofmann(Universität Ulm), Zeguang Wu(Peking University), Thomas Mertens(University Hospital Ulm), Donald Bunjes(University Hospital Ulm), Anita Schmitt(Heidelberg University), Paul Schnitzler(Heidelberg University)
Cited by 11
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k